Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195222 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-20 | 2023-07-12 | 195839 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197507 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-13 | 2023-10-04 | 198602 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-08-03 | 2023-08-18 | 200873 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-10-05 | 2023-12-07 | 206371 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-01-18 | 2024-03-07 | 216457 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-03-21 | 2024-04-05 | 222935 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-04-11 | 2024-05-03 | 224883 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-04-03 | 2017-05-23 | 5165 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2019-06-27 | 2020-03-19 | 87680 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2020-03-26 | 2020-05-21 | 109571 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167229 |
| TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120878 |
| TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120476 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |